Comment on: “Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis”
Letter to the Editor

Comment on: “Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis

Xiangyu Liu1, Meilin Zhu2

1Department of Gastroenterology, Jining First People’s Hospital, Jining, China; 2Department of Geriatrics, Jining First People’s Hospital, Jining, China

Correspondence to: Meilin Zhu, MM. Department of Geriatrics, Jining First People’s Hospital, Jining, China. Email: zxzx8383@126.com.

Comment on: Hong J, Cao L, Xie H, et al. Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis. Hepatobiliary Surg Nutr 2021;10:623-30.


Submitted Mar 15, 2022. Accepted for publication Apr 14, 2022.

doi: 10.21037/hbsn-22-99


We are grateful to Hepatobiliary Surg Nutr for publishing the study entitled “Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis”. In this well-designed study, the authors concluded that in patients with small hepatocellular carcinoma, stereotactic body radiation therapy has a higher local control rate but poorer prognosis than radiofrequency ablation; in addition, the local toxicity of the two treatments was comparable (1). While we read the article with pleasure, it must be noted that this study raises some thought-provoking issues.

There is common agreement that systematic reviews must be conducted and reported according to the highest methodological standards. For example, review registration is mandatory, and detailed study registration information should be highlighted and explained in the article. Registering a systematic review protocol is important as it enables the promotion of transparency and avoidance of potential biases including both selection and selective outcome reporting biases.

Second, the authors should further optimize the search strategy and expand the scope of the databases to avoid the omission of qualified literature. In this meta-analysis, the databases mentioned in the authors’ article are still inadequate in our view. If some other English databases including Google Scholar, Scopus, NLM Gateway and PsycINFO can also be searched, then it may increase the target articles and thus improve the persuasiveness of the outcomes. In addition, the authors stated in the text that there were no language restrictions, thus many Chinese databases such as Wanfang, CNKI, Taiwan Electronic Periodical Services, and China National Knowledge Infrastructure should also be searched.

We also recommend that authors should detail the quality assessment protocol for the included literature in the methods section of the article. The authors stated that five retrospective studies were included, but the evaluation method used was only applicable to randomized controlled trials. We recommend using a Newcastle-Ottawa scale (2) or a modified version of the Downs and Black tool (3) to assess the quality of the studies. In addition, the authors considered the three included studies were randomized; however, we suggest that the authors should carefully evaluate the quality of each article, since randomization is not possible in retrospective studies.

We are grateful to Hong et al. for contributing to this important meta-analysis that can guide clinical decision-making. However, high-quality studies with large sample sizes are still needed to continue to clarify this issue.


Acknowledgments

Funding: None.


Footnote

Provenance and Peer Review: This article was a standard submission to the journal. The article did not undergo external peer review.

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-22-99/coif). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Hong J, Cao L, Xie H, et al. Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis. Hepatobiliary Surg Nutr 2021;10:623-30. [Crossref] [PubMed]
  2. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603-5. [Crossref] [PubMed]
  3. Doi SA, Barendregt JJ, Khan S, et al. Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model. Contemp Clin Trials 2015;45:130-8. [Crossref] [PubMed]
Cite this article as: Liu X, Zhu M. Comment on: “Stereotactic body radiation therapy versus radiofrequency ablation in patients with small hepatocellular carcinoma: a systematic review and meta-analysis”. Hepatobiliary Surg Nutr 2022;11(4):647-648. doi: 10.21037/hbsn-22-99

Download Citation